thalidomide对患有系统性硬化症相关的间歇性肺病患者的治疗效果
1Department of Rheumatology and Immunology, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Journal of scleroderma and related disorders
|September 25, 2023
概括
thalidomide与环胺结合使用改善了系统性硬化症相关的间歇性肺病患者的咳和吐. 然而,这种联合治疗增加了不良事件,尽管可能延迟了肺纤维化进展.
科学领域:
- 类风湿病学 类风湿病学
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 系统性硬化症相关的间歇性肺病 (SSc-ILD) 是一种严重的并发症,影响患者的预后.
- 目前用于SSc-ILD的治疗方法通常具有有限的疗效和显著的副作用.
研究的目的:
- 评估在治疗SSc-ILD时,thalidomide与环胺结合的临床疗效和安全性.
- 为了比较组合治疗与单一治疗的结局.
主要方法:
- 一项研究包括96名接受葡萄糖皮质体治疗的SSc-ILD患者.
- 患者被分为一种thalidomide组 (thalidomide + cyclophosphamide) 和一种控制组 (cyclophosphamide单疗法).
- 评估包括临床症状,皮肤得分,肺功能,CT成像和24周的不良事件.
主要成果:
- 塔利多米德组在咳,吐和皮肤得分方面显著改善.
- 在thalidomide组中,肺纤维化和一氧化碳扩散能力的改善被注意到.
- 与对照组 (33.3%) 相比,thalidomide组的不良事件发生率更高 (64.6%).
结论:
- 沙利多米德与环胺结合可以缓解SSc-ILD患者的呼吸道症状.
- 这种联合治疗可能会稍微延迟肺纤维化进展.
- 增加不良事件的风险需要在thalidomide联合治疗期间进行仔细监测.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
186
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
186
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
164
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
164
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
144
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
144
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
289
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
289
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
727
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
727
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
191
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
191